2026 NPPES data Dermatopathology Physician NPI 1265407852 MD
Verify on CMS →

ROBERT HERTEN, MD

Dermatopathology Physician in SAN LUIS OBISPO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
461
Medicare Part D claims · 202 beneficiaries · Dermatopathology Physician avg: 650
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]

What the federal data shows

ROBERT HERTEN, MD reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 461 Medicare Part D claims in 2023.

0/100
MIPS score · -83 vs avg
461
Part D claims, 2023
97%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ROBERT HERTEN, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

0 0th percentile higher than 0% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ROBERT HERTEN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ROBERT HERTEN, MD?

Below national average

NPI registry status

Active

Issued 02/17/2006

NPI 1265407852

Primary specialty

Dermatopathology Physician

Niche

570 US NPIs in this specialty

Medicare Part D claims

461 29% vs specialty avg

2023 prescription claims

Specialty avg: 650

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in California

How Dermatopathology Physician compares to other specialties among California providers

California providers

Dermatopathology Physician share within California

1. Dermatopathology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatopathology Physician share within California

Medicare quality performance — MIPS

ROBERT HERTEN, MD's 2023 MIPS final score plotted against the Dermatopathology Physician national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatopathology Physician) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Dermatopathology Physician) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT HERTEN, MD appears in the CMS NPPES registry as a Dermatopathology Physician provider holding MD credentials at 15 SANTA ROSA ST, SAN LUIS OBISPO, CA, 93405, with a listed phone of (805) 541-2650. NPI 1265407852 was issued on 02/17/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HERTEN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 461 prescription claims written by this provider, covering 202 Medicare beneficiaries and totaling roughly $42K in drug spend, split 3% brand-name and 97% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Dermatopathology Physician is a narrow specialty nationwide, with 570 enrolled providers across 48 states and an average of 650 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

15 SANTA ROSA ST
SAN LUIS OBISPO, CA 93405

Provider Details

NPI 1265407852
Specialty Dermatopathology Physician
Credentials MD
Gender Male
NPI Issued 02/17/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ROBERT HERTEN, MD. To verify ROBERT HERTEN, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

ROBERT HERTEN, MD — brand share 3.0%
Specialty average (est.)

3% brand-name claims vs 97% generic, on 461 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

461
Total Claims
$42K
Total Drug Cost
202
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
584
Total Day Supply
15,404
Brand vs Generic
3% brand / 97% generic
Brand Drug Cost
$26K
Generic Drug Cost
$16K
Antibiotic Claims
43

Patient Demographics

Average Patient Age
77.1 years
Avg HCC Risk Score
0.93
Gender Split
56% female / 44% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ROBERT HERTEN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Mupirocin
83
Triamcinolone Acetonide
62
Acyclovir
48
Doxycycline Hyclate
33
Clobetasol Propionate
32
Ketoconazole
32
Betamethasone Diprop Augmented
Betamethasone/Propylene Glyc
23
Desonide
15
Spironolactone
15
Metronidazole
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatopathology Physician Overview

How ROBERT HERTEN, MD fits within the Dermatopathology Physician landscape nationally.

570
Dermatopathology Physician Providers in US
48
States with Dermatopathology Physician
650
Avg Claims per Provider

ROBERT HERTEN, MD's 461 claims are below the specialty average of 650.

Nearby Dermatopathology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as HERTEN.

Compare Dermatopathology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT HERTEN, MD's specialty?
ROBERT HERTEN, MD specializes in Dermatopathology Physician and practices in SAN LUIS OBISPO, California. Credentials: MD.
How much does ROBERT HERTEN, MD prescribe under Medicare Part D?
In 2023, ROBERT HERTEN, MD wrote 461 Medicare Part D claims totaling $42K in drug costs for 202 beneficiaries.
What is ROBERT HERTEN, MD's Medicare quality score?
ROBERT HERTEN, MD has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ROBERT HERTEN, MD located?
ROBERT HERTEN, MD is located at 15 SANTA ROSA ST, SAN LUIS OBISPO, CA, 93405. Phone: (805) 541-2650.
What is ROBERT HERTEN, MD's NPI number?
ROBERT HERTEN, MD's National Provider Identifier (NPI) is 1265407852, issued on 02/17/2006.
Does ROBERT HERTEN, MD prescribe more brand-name or generic drugs?
ROBERT HERTEN, MD's prescribing is 3% brand-name and 97% generic drugs by claim count, with $26K in brand drug costs.
How many Dermatopathology Physician providers are there in the US?
There are 570 Dermatopathology Physician providers across 48 states in the US. The average Dermatopathology Physician provider writes 650 Medicare Part D claims per year.
What drugs does ROBERT HERTEN, MD prescribe most often?
Based on 2023 Medicare Part D data, ROBERT HERTEN, MD's most frequently prescribed drugs include Mupirocin, Triamcinolone Acetonide, Acyclovir. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT HERTEN, MD accept Medicare?
ROBERT HERTEN, MD appears in CMS Medicare data with 461 Part D claims and 202 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT HERTEN, MD's credentials?
ROBERT HERTEN, MD's NPI is 1265407852 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology